Boulding Mark Elliottinsider trades
In SEC Form 4 filings, Boulding Mark Elliott is listed as EXEC. VP AND CLO of Ptc Therapeutics, Inc. (PTCT). In the last 90 days, Boulding Mark Elliott sold $145.1K of Ptc Therapeutics, Inc. (PTCT) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| PTCTPtc Therapeutics, Inc. | EXEC. VP AND CLO | 9 | Oct 13 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-07
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| PTCTPtc Therapeutics, Inc. | Oct 9 | Oct 13 | M | 192 | $39.42 | $7,569 | 105,464 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Oct 9 | Oct 13 | S | 192 | $64.26 | Sale −$12,338 | 105,272 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Oct 9 | Oct 13 | M · derivative | 192 | $39.42 | $7,569 | 2,267 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Oct 6 | Oct 7 | M | 435 | $39.42 | $17,148 | 105,707 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Oct 6 | Oct 7 | S | 435 | $64.16 | Sale −$27,910 | 105,272 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Oct 6 | Oct 7 | M · derivative | 435 | $39.42 | $17,148 | 2,459 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Oct 5 | Oct 7 | M | 1,638 | $39.42 | $64,570 | 106,910 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Oct 5 | Oct 7 | S | 1,638 | $64.03 | Sale −$104,881 | 105,272 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Oct 5 | Oct 7 | M · derivative | 1,638 | $39.42 | $64,570 | 2,894 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.